LexisNexis® Legal Newsroom
Australian Court: Vioxx Doubled Heart Attack Risk

SYDNEY, Australia – (AP) The once-popular painkiller Vioxx doubled the risk of heart attack and was unfit for consumption, an Australian court ruled Friday, awarding a man leading a class action suit against the drug's maker 287,000 Australian dollars ($259,000) in compensation. Melbourne...

Supreme Court Says Vioxx Lawsuit Can Proceed

WASHINGTON, D.C. – (AP) The Supreme Court said Tuesday investors who lost millions betting on the blockbuster drug Vioxx can sue Merck & Co. over whether the pharmaceutical giant provided enough information about the painkiller's risks before it was pulled from the market. The high court...

High Court Upholds 3rd Circuit's Ruling, Finds Stockholder's Suit Against Merck Was Timely

WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on April 27 affirmed a Third Circuit U.S. Court of Appeals ruling that a shareholder derivative lawsuit over Merck & Co. Inc.'s marketing of Vioxx was timely and held that the statute of limitations on a claim under Section 10(b) of the...

Merck: The Statute of Limitations in Securities Fraud Damage Suits

In a result joined by all of the justices, the Supreme Court affirmed the decision of the Third Circuit, concluding that plaintiffs' had timely filed a securities fraud suit against Merck & Co. Merck & Co. v. Reynolds , Case No. 08-905 S.Ct. (April 27, 2010). The case centers on alleged...

Merck & Co. v. Reynolds, 2010 U.S. LEXIS 3671 (Apr. 27, 2010)

LexisNexis Overview: "Discovery" of facts that put investors on "inquiry notice" did not automatically begin 28 U.S.C.S. § 1658(b)'s limitations period, and since scienter was a "fact" and an FDA warning letter and products liability suits showed little if nothing...

Merck: The Statute Of Limitations In Securities Fraud Damage Suits

In a result joined by all of the justices, the Supreme Court affirmed the decision of the Third Circuit, concluding that plaintiffs' had timely filed a securities fraud suit against Merck & Co. Merck & Co. v. Reynolds , Case No. 08-905 S.Ct. (April 27, 2010). The case centers on alleged...

Oil Spill Legal Mess Likely One Of Costliest Ever

MIAMI - (AP) BP PLC and the other companies involved in the Gulf of Mexico oil spill are faced with fast-multiplying lawsuits that will provoke one of the most drawn-out and costliest legal battles in U.S. history, one that could easily consume the $20 billion set aside by BP to pay. . . . Full version...

Federal Vioxx Judge Awards $315.3 Million To Core Attorney Group

NEW ORLEANS - (Mealey's) The judge supervising the Vioxx multidistrict litigation on Oct. 19 awarded $315.3 million to the group of attorneys who conducted discovery and other work of benefit to all federal litigants and those participating in the $4.85 billion settlement with Merck & Co. ( In...

Lead Attorneys In Vioxx Settlement Get $315.3M

NEW ORLEANS - (AP) The federal judge overseeing the thousands of lawsuits filed over withdrawn painkiller Vioxx has ruled that the lead lawyers in the case will get $315.3 million, while other lawyers who sued Merck & Co. will share $1.2 billion. U.S. District Judge Eldon J. Fallon, in a ruling Tuesday...

Burg Simpson Leads National Litigation Against DePuy Orthopaedics

DENVER - Burg Simpson Eldredge Hersh & Jardine P.C., one of the nation's leading plaintiff litigation law firms, has announced that shareholder Seth. A. Katz has been appointed by Judge David A. Katz to serve as a member of the Plaintiffs' Steering Committee in the multidistrict litigation...

Michigan Drug Shield Dooms False Claims Act Lawsuit

TROY, Mich. - (Mealey's) Michigan's attempt to obtain reimbursement under its Medicaid False Claim Act (MFCA) for money spent on Vioxx was thwarted March 17 by the state's own pharmaceutical liability shield when the state's Second District Court of Appeals reversed a circuit court decision...

Lawsuits Follow Diabetes Drug Actos' Link To Cancer Risk

TRENTON, N.J. - (AP) The maker of the world's best-selling diabetes drug is facing hundreds of lawsuits and likely a big sales drop as suspicion grows that taking the pill for more than a year raises the risk of bladder cancer. In June, Takeda Pharmaceuticals Co. Ltd. halted sales of Actos. . . ...

Merck Settles Charges Over Vioxx Marketing For $950M, Guilty Plea

BOSTON - Merck, Sharp & Dohme Inc. has agreed to plead guilty to a criminal misdemeanor and to pay $950 million to resolve criminal charges and civil claims stemming from its marketing of the painkiller Vioxx a decade ago, the U.S. Department of Justice announced yesterday ( United States v....

Merck, Canadian Plaintiffs Settle Vioxx Litigation For Up To $36.3 Million

(Mealey's) Merck Sharp & Dohme Corp. and plaintiffs' counsel in four Canadian Vioxx class actions announced Jan. 19 that they have agreed to settle the litigation for up to $36.3 million ( Mignacca, et al. v. Merck Frosst Canada Ltd, et al. , No. 04-CV-045435CP, Ontario Super. Ct. of Justice;...